Search
Processa Pharmaceuticals Inc
PCSAAdd to Watchlist
2.570USD
+0.270+11.74%
Close 08-07 16:00（ET）Quotes delayed by 15 min
8.61MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-07No earnings forecast score is currently available for Processa Pharmaceuticals Inc. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 1.00, with a high of 1.00 and a low of 1.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
25.000
Target Price
+986.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Processa Pharmaceuticals Inc
PCSA
0
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Processa Pharmaceuticals Inc's price target?
Analysts forecast that Processa Pharmaceuticals Inc's price target is USD 1.00, with the highest forecast at USD 1.00 and the lowest forecast at USD 1.00.
How have Processa Pharmaceuticals IncPCSA's recent earnings per share performed?
The market expectation was USD -1.29, while Processa Pharmaceuticals IncPCSA's earnings per share (EPS) for the previous quarter was USD -1.49. EPS for the next quarter is expected at USD -1.00.